𝔖 Bobbio Scriptorium
✦   LIBER   ✦

RAISED NEURON-SPECIFIC ENOLASE IN SERUM OF CHILDREN WITH METASTATIC NEUROBLASTOMA *1A Report from the Children's Cancer Study Group

✍ Scribed by ZELTZER, P

Book ID
122804791
Publisher
The Lancet
Year
1983
Tongue
English
Weight
419 KB
Volume
322
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

13-cis-retinoic acid (NSC 122758) in the
13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: Report from the childrens cancer study group
✍ Finklestein, Jerry Z. ;Krailo, Mark D. ;Lenarsky, Carl ;Ladisch, Stephen ;Blair, πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 428 KB

## Abstract The Childrens Cancer Study Group evaluated daily oral 13‐cis‐retinoic acid to determine its therapeutic efficacy in 28 children with advanced neuroblastoma refractory to conventional therapy. Cheilitis and fissured lips were the most common side effects; however, fewer than 50% of the p

Opsoclonus-myoclonus-ataxia syndrome in
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies?a report from the children's cancer group study
✍ Rudnick, Emily ;Khakoo, Yasmin ;Antunes, Nuno L. ;Seeger, Robert C. ;Brodeur, Ga πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 159 KB

## Abstract ## Background Opsoclonus‐myoclonus‐ataxia (OMA) is a paraneoplastic neurologic syndrome affecting 2–3% of children with neuroblastoma. Although children with OMA and neuroblastoma may have higher survival, many experience a significant amount of late neurologic impairment, which may be